医学界神经频道|获国际权威指南最高级别推荐,新一代抗癫痫药有何“过人之处”?( 二 )

医学界神经频道|获国际权威指南最高级别推荐,新一代抗癫痫药有何“过人之处”?
本文插图
图3. 吡仑帕奈作用机制小结近年来 , 抗癫痫药物发展迅速 , 癫痫患者的治疗面临诸多选择 。 作为目前首个且唯一的AMPA受体拮抗剂 , 吡仑帕奈可有效控制癫痫发作 , 且安全性良好 , 不影响青少年患者的认知 。 基于其优异疗效和安全性 , 目前吡仑帕奈已获得了国际权威指南最高级别推荐 , 在癫痫治疗中的地位毋庸置疑 。 2019年12月 , 吡仑帕奈正式在中国上市 。 期待未来随着中国数据和临床经验的积累 , 给中国更多癫痫患者带来获益!参考文献:1.姚刚, 朱元贵, 曹河圻, 等. 国家自然科学基金资助癫痫研究十年回顾与展望[J]. 中华神经创伤外科电子杂志, 2020,06(03) : 129-134.2.French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1261–1273.3.Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology[J]. Epilepsy Curr. Jul-Aug 2018;18(4):269-278.4.Steinhoff BJ, Ben-Menachem E, Ryvlin P, et al. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies[J]. Epilepsia. 2013 Aug;54(8):1481-9.5.Lin KL, Lin JJ, Chou ML, et al. Efficacy and tolerability of perampanel in children and adolescents with pharmacoresistant epilepsy: The first real-world evaluation in Asian pediatric neurology clinics[J]. Epilepsy Behav. 2018 Aug;85:188-194.6.Faulkner MA. Perampanel: a new agent for adjunctive treatment of partial seizures[J]. Am J Health Syst Pharm. 2014 Feb 1;71(3):191-8.7.Rugg-Gunn F. Adverse effects and safety profile of perampanel: a review of pooled data[J]. Epilepsia. 2014 Jan;55 Suppl 1:13-5.8.史卫忠, 徐春敏, 韩容. 新型口服抗癫痫药吡仑帕奈[J]. 药品评价. 2012; 9(29): 33-37.
【医学界神经频道|获国际权威指南最高级别推荐,新一代抗癫痫药有何“过人之处”?】


推荐阅读